Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 4
2009 5
2010 1
2011 5
2012 4
2014 4
2015 1
2016 3
2017 4
2018 8
2019 9
2020 3
2021 6
2022 6
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Sustained release of a human PD-L1 single-domain antibody using peptide-based hydrogels.
Heremans J, Maximilian Awad R, Bridoux J, Ertveldt T, Caveliers V, Madder A, Hoogenboom R, Devoogdt N, Ballet S, Hernot S, Breckpot K, Martin C. Heremans J, et al. Among authors: hernot s. Eur J Pharm Biopharm. 2024 Mar;196:114183. doi: 10.1016/j.ejpb.2024.114183. Epub 2024 Jan 19. Eur J Pharm Biopharm. 2024. PMID: 38246566
Safety assessment of fluorescently labeled anti-EGFR Nanobodies in healthy dogs.
do Valle NCH, Janssen S, Stroet MCM, Pollenus S, Van den Block S, Devoogdt N, Debacker JM, Hernot S, De Rooster H. do Valle NCH, et al. Among authors: hernot s. Front Pharmacol. 2023 Sep 14;14:1266288. doi: 10.3389/fphar.2023.1266288. eCollection 2023. Front Pharmacol. 2023. PMID: 37781693 Free PMC article.
Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targeting.
Erreni M, D'Autilia F, Avigni R, Bolli E, Arnouk SM, Movahedi K, Debie P, Anselmo A, Parente R, Vincke C, van Leeuwen FWB, Allavena P, Garlanda C, Mantovani A, Doni A, Hernot S, Van Ginderachter JA. Erreni M, et al. Among authors: hernot s. Theranostics. 2023 Jan 1;13(1):355-373. doi: 10.7150/thno.77560. eCollection 2023. Theranostics. 2023. PMID: 36593955 Free PMC article.
Impact of doubling peptide length on in vivo hydrogel stability and sustained drug release.
Heremans J, Chevillard L, Mannes M, Mangialetto J, Leroy K, White JF, Lamouroux A, Vinken M, Gardiner J, Van Mele B, Van den Brande N, Hoogenboom R, Madder A, Caveliers V, Mégarbane B, Hernot S, Ballet S, Martin C. Heremans J, et al. Among authors: hernot s. J Control Release. 2022 Oct;350:514-524. doi: 10.1016/j.jconrel.2022.08.027. Epub 2022 Sep 1. J Control Release. 2022. PMID: 35998769
Emerging applications of nanobodies in cancer therapy.
Awad RM, Meeus F, Ceuppens H, Ertveldt T, Hanssens H, Lecocq Q, Mateusiak L, Zeven K, Valenta H, De Groof TWM, De Vlaeminck Y, Krasniqi A, De Veirman K, Goyvaerts C, D'Huyvetter M, Hernot S, Devoogdt N, Breckpot K. Awad RM, et al. Among authors: hernot s. Int Rev Cell Mol Biol. 2022;369:143-199. doi: 10.1016/bs.ircmb.2022.03.010. Epub 2022 May 18. Int Rev Cell Mol Biol. 2022. PMID: 35777863
64 results